BTC $80,035.74 -1.61%
ETH $2,318.14 -2.02%
BNB $752.20 +0.47%
XRP $1.29 -2.95%
SOL $100.20 -2.25%
TRX $0.3310 -0.15%
DOGE $0.0780 -2.49%
ADA $0.1994 -3.53%
BCH $279.85 -6.31%
LINK $11.47 -2.61%
HYPE $79.05 -3.31%
AAVE $130.69 -3.15%
SUI $0.9120 -2.83%
XLM $0.1684 -1.85%
ZEC $1,247.92 -4.98%
AAPL $347.85 +0.37%
AMZN $252.95 -0.41%
GOOGL $292.52 -9.93%
MSFT $551.94 +4.13%
META $621.63 -0.26%
NVDA $214.50 -2.37%
TSLA $402.73 -1.68%
SNDK $1,365.50 +0.26%
INTC $92.50 -2.99%
SPCX $144.32 -3.78%
MU $955.64 -0.95%
AMD $564.52 -0.80%
BTC $80,035.74 -1.61%
ETH $2,318.14 -2.02%
BNB $752.20 +0.47%
XRP $1.29 -2.95%
SOL $100.20 -2.25%
TRX $0.3310 -0.15%
DOGE $0.0780 -2.49%
ADA $0.1994 -3.53%
BCH $279.85 -6.31%
LINK $11.47 -2.61%
HYPE $79.05 -3.31%
AAVE $130.69 -3.15%
SUI $0.9120 -2.83%
XLM $0.1684 -1.85%
ZEC $1,247.92 -4.98%
AAPL $347.85 +0.37%
AMZN $252.95 -0.41%
GOOGL $292.52 -9.93%
MSFT $551.94 +4.13%
META $621.63 -0.26%
NVDA $214.50 -2.37%
TSLA $402.73 -1.68%
SNDK $1,365.50 +0.26%
INTC $92.50 -2.99%
SPCX $144.32 -3.78%
MU $955.64 -0.95%
AMD $564.52 -0.80%

The listed company Galmed plans to allocate 50% of its cash reserves to cryptocurrency

2025-08-25 20:00:41

ChainCatcher news, according to PR Newswire, the US-listed biopharmaceutical company Galmed Pharmaceuticals Ltd. announced the implementation of a digital asset management strategy, with plans to allocate $10 million (approximately 50% of current cash reserves) for digital asset investments.

The company has established a cryptocurrency committee responsible for evaluating and overseeing cryptocurrency-related investment activities. This strategy will include digital asset portfolio rebalancing, participation in liquidity provision, staking yields, and risk hedging strategies.

To execute this plan, Galmed has signed a letter of intent with cryptocurrency asset management service provider Tectona (TASE: TECT), which will provide consulting and operational services.

app_icon
ChainCatcher Building the Web3 world with innovations.